Jenapharm Gmbh & Co. Kg

Bayer Pharma Aktiengesellschaft

Ralf Ladwig

Michael Oettel

Michael Dittgen

Sabine Fricke

Guenter Kaufmann

Carsten Timpe

Holger Zimmermann

Sven Claussen

Doris Huebler

Manfred Boese

Claus Claussen

Manuela Pfeifer

Beate Bürglen

The method of making a bioadhesive tablet for controlling testosterone blood level, especially in elderly men suffering from partial androgen deficiency, includes spray-drying an alcoholic solution or suspension of testosterone and at least one testosterone ester, preferably in a ratio of 1:10 to 1:1.5, separately or together, with an organic polymer and optionally one or more auxiliary ingredient to form an active ingredient premix. Then various other auxiliary ingredients are mixed, as needed, with the active ingredient premix to form the bioadhesive tablet with an active ingredient layer and an adhesive layer. The active ingredient layer contains an effective amount of the active ingredient premix. The adhesive layer includes auxiliary ingredients including the bioadhesive polymer. The bioadhesive tablet may be buccally administered to provide a predetermined timed release profile of testosterone, advantageously varying according to a circadian rhythm.

Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same

Growing community of inventors

Jena, Germany

Ralf Ladwig